STOCK TITAN

[SCHEDULE 13G/A] Ovid Therapeutics Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Rubric Capital Management LP
Signature:/s/ Michael Nachmani
Name/Title:Michael Nachmani / Chief Operating Officer
Date:07/08/2025
David Rosen
Signature:/s/ David Rosen
Name/Title:David Rosen / Individually
Date:07/08/2025
Ovid Therapeutics Inc

NASDAQ:OVID

OVID Rankings

OVID Latest News

OVID Latest SEC Filings

OVID Stock Data

81.06M
59.51M
16.31%
34.69%
1.79%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK